The cobalamin enters the bloodstream directly and is available to tissues within hours
Not all prescribers endorse this approach, so discuss it with yours first
Don't let high costs prevent you from experiencing the transformative benefits of peptide therapy
The biggest risk is the lack of safety evidence
In 2023, during Bidens Presidency, the Food and Drug Administration placed nineteen peptides, including BPC-157, on a do not compound list, citing potential significant safety risks that included immune reactions, pancreatitis, and accelerated growth of cancerous cells
BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from a protective protein found in stomach acid